Investigation of prevalence of MRSA in referrals to neurosurgery: Implications for antibiotic prophylaxis

British Journal of Neurosurgery

Volumn 16, Issue 6, 2002, Pages 550-554

  Hammond, C J ^a   Gill, J ^a   Peto, T E A ^a   Cadoux Hudson, T A D ^a   Bowler, I C J W ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibiotic prophylaxis; Gentamicin; MRSA; Neurosurgery; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM ISOLATE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUROSURGERY; PATIENT TRANSPORT; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM; WOUND INFECTION;

EID: 0036938955     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688690209168359     Document Type: Article

References (16)

1. Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-16.
2. Troillet NT, Carmeli Y, Samore MH, et al. Carriage of methicillin-resistant Staphylococcus aureus at hospital admission. Infect Control Hosp Epidemiol 1998;19: 181-5.
3. De Louvois J. Antimicrobial prophylaxis in neurosurgery and after head injury. Lancet 1994;344: 1547-51.
4. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, ed., APIC infection control and applied epidemiology: principles and practice. London: Mosby, 1996:A1-A20 (Available at: www.apic.org/pdf/cdcdefs.pdf) Accessed 5 July 2002.
5. Silvestri L, Monti Bragadin C, Milanese M, et al. Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients. J Hosp Infect 1999;42:125-33.
6. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995; 31:13-24.
7. Henwood CJ, Livermore DM, Johnson AP, James D, Warner M, Gardiner A and the linezolid Study Group. Susceptibility of Gram-positive cocci from 25 hospitals to antimicrobial agents including linezolid. J Antimicrob Chemother 2000;46:93-40.
8. Doebbeling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonization and infection. J Chemother 1995;7(Suppl 3):99-103.
9. Dempsey R, Rapp RP, Young B, Johnston S, Tibbs P. Prophylactic parenteral antibiotics in clean neurosurgical procedures: a review. J Neurosurg 1988;69:52-7.
10. Tenney JH, Vlahov D, Salcman M, Ducker TB. Wide variation in risk of wound infection following clean neurosurgery. J Neurosurg 1985;62:243-4.
11. Levy JH, Kettlekamp N, Goertz P, Hermens J, Hirshman CA. Histamine release by vancomycin: a mechanism for hypotension in man. Anesthesiology 1987;67:122-5.
12. Dajee H, Laks H, Miller J, Oren R. Profound hypotension from rapid vancomycin administration during cardiac operation. J Thorac Cardiovasc Surg 1984; 87:145-6.
13. von Kaenel WE, Bloomfield EL, Amaranath L, Wilde AA. Vancomycin does not enhance hypotension under anesthesia. Anesth Analg 1993;76:809-11.
14. Fraise AP. The treatment and control of vancomycin resistant enterococci. J Antimicrob Chemother 1996;38: 753-6.
15. Kucers A, Crowe SM, Grayson ML, Hoy JF. The use of antibiotics, 5th edn. Oxford: Butterworth Heinemann, 1997:450-88.
16. Haines SJ. Efficacy of antibiotic prophylaxis in clean neurosurgical operations. Neurosurgery 1989;24:401-5.